Search Results
107 items found for "Acute lung injury"
Posts (70)
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction Purpose: This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute Conclusion: Exendin-4 inhibits the remodeling in the remote myocardium of rats following acute MI by
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
Objective: The goal of this study was to determine the glucometabolic effects of acute activation of expressed by SKM at relatively high levels (β2-adrenergic receptor and CRF2 receptor) and studied the acute Results: Acute stimulation of GsD signaling in SKM impaired glucose tolerance in lean and obese mice The acute metabolic effects following agonist activation of β2-adrenergic and, potentially, CRF2 receptors The acute metabolic effects of UCN2 were not mediated by SKM Gs signaling.
- 📰 GPCR Weekly News, December 4 to 10, 2023
use disorder GPCRs in Oncology and Immunology Regulator of G protein signaling protein 6 alleviates acute lung injury by inhibiting inflammation and promoting cell self-renewal in mice Methods & Updates in
Other Pages (37)
- Ep 134 with Dr. Neil Grimsey
atypical p38 signaling responses we are studying how atypical p38 controls the onset and pathogenesis of acute lung injury, retinal vasculopathies, and infections. " Dr.
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
Immunology Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung Published date July 3, 2023 Abstract "Despite campaigns and improvements in detection and treatment, lung One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed Since lung cancer is often diagnosed in advanced stages, our efforts should focus on early diagnosis, Furthermore, their modulation could be considered as a promising approach in lung cancer therapeutics
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia Published date November 1, 2023 Abstract "PLK1 is overexpressed in acute myeloid leukemia